ChromoTek TIM3 VHH, recombinant binding protein for 2x Cys conjugation
Alpaca anti-TIM3 VHH, purified recombinant binding protein. Suitable for for cysteine conjugation with thiol-reactive reagents, e.g. maleimides. Note: unconjugated VHHs are not suited for usage without prior labeling, since they contain reactive Cysteines. Shipment and storage buffers contain TCEP to keep Cysteins reduced.
Cat no : tmtCys2
Synonyms
Validation Data Gallery
Product Information
Alpaca anti-TIM3 VHH, purified recombinant binding protein. Suitable for for cysteine conjugation with thiol-reactive reagents, e.g. maleimides. Note: unconjugated VHHs are not suited for usage without prior labeling, since they contain reactive Cysteines. Shipment and storage buffers contain TCEP to keep Cysteins reduced.
Applications | Conjugation |
Reactivity | Human |
Conjugate | Unconjugated |
Type | Nanobody |
Class | Recombinant |
Host | Alpaca |
Affinity | in the picomolar range, below the assay limit (biolayer interferometry) |
Molecular Weight | 14.824 kDa |
Form | Liquid |
RRID | AB_3101920 |
Storage Buffer | 10 mM HEPES, 500 mM NaCl, pH 7.0, 1 mM TCEP, 0.09% sodium azide |
Storage Condition | Store at -20°C; Avoid exposure to light. Shipped at dry ice. |
Background | TIM3, also known as HAVCR2, is a member of the recently discovered T cell Ig and mucin domain-containing molecule superfamily. TIM3 is a negative regulatory molecule that is important for T cell tolerance and has a crucial role in autoimmunity and T cell exhaustion during chronic viral infection (PMID: 23180819). TIM3 is expressed by T-helper type 1 (Th1) cells, macrophage, monocyte, dendritic cells, CD8+ T cell and other lymphocyte subsets. Galectin-9 is a ligand for TIM3. TIM3-galectin-9 pathway negatively regulates T helper type 1 immunity (PMID: 16286920). TIM3 is a 280-aa membrane protein with a calculated molecular weight of 33 kDa, the higher molecular weights between 50 and 70 kDa detected by this monoclonal antibody probably represent glycosylated TIM3 (PMID: 20107545; 17069754; 11725301). |
Documentation
SDS |
---|
SDS_Immuno-Oncology VHHs (grouped) |